DEA adds biometrics in interim final rule on e-Rx of controlled drugs

03/25/2010 | Government Health IT magazine

In its interim final rule planned for release by end of March, the Drug Enforcement Administration has added biometric technology to existing methods of authenticating e-prescription orders on controlled drugs. "While DEA is uncertain about the extent to which existing biometric readers will be used in healthcare settings, DEA believes it is reasonable to allow for such technology because the technology is likely to improve," the agency said in a notice.

View Full Article in:

Government Health IT magazine

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA